These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 39107144)
1. Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study. Vande Casteele T; Laroy M; Van Cauwenberge M; Vanderlinden G; Vansteelandt K; Koole M; Dupont P; Van Den Bossche M; Van den Stock J; Bouckaert F; Van Laere K; Emsell L; Vandenbulcke M Am J Geriatr Psychiatry; 2024 Jul; ():. PubMed ID: 39107144 [TBL] [Abstract][Full Text] [Related]
2. Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression. Takamiya A; Vande Casteele T; Koole M; De Winter FL; Bouckaert F; Van den Stock J; Sunaert S; Dupont P; Vandenberghe R; Van Laere K; Vandenbulcke M; Emsell L Sci Rep; 2021 Aug; 11(1):15981. PubMed ID: 34354136 [TBL] [Abstract][Full Text] [Related]
3. Quantitative Zhao Q; Liu M; Ha L; Zhou Y; Front Neurol; 2019; 10():486. PubMed ID: 31156534 [TBL] [Abstract][Full Text] [Related]
5. Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study. Wan K; Yin W; Tang Y; Zhu W; Wang Z; Zhou X; Zhang W; Zhang C; Yu X; Zhao W; Li C; Zhu X; Sun Z J Alzheimers Dis; 2023; 92(1):81-93. PubMed ID: 36710682 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
7. The effects of cerebral amyloidopathy on regional glucose metabolism in older adults with depression and mild cognitive impairment while performing memory tasks. Lee ES; Youn H; Hyung WSW; Suh S; Han CE; Eo JS; Jeong HG Eur J Neurosci; 2021 Oct; 54(7):6663-6672. PubMed ID: 34528336 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal tau PET in ageing and Alzheimer's disease. Jack CR; Wiste HJ; Schwarz CG; Lowe VJ; Senjem ML; Vemuri P; Weigand SD; Therneau TM; Knopman DS; Gunter JL; Jones DT; Graff-Radford J; Kantarci K; Roberts RO; Mielke MM; Machulda MM; Petersen RC Brain; 2018 May; 141(5):1517-1528. PubMed ID: 29538647 [TBL] [Abstract][Full Text] [Related]
9. When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression. Liguori C; Pierantozzi M; Chiaravalloti A; Sancesario GM; Mercuri NB; Franchini F; Schillaci O; Sancesario G Front Aging Neurosci; 2018; 10():38. PubMed ID: 29527163 [TBL] [Abstract][Full Text] [Related]
10. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558 [TBL] [Abstract][Full Text] [Related]
11. The Leuven late life depression (L3D) study: PET-MRI biomarkers of pathological brain ageing in late-life depression: study protocol. Emsell L; Laroy M; Van Cauwenberge M; Vande Casteele T; Vansteelandt K; Van Laere K; Sunaert S; Van den Stock J; Bouckaert F; Vandenbulcke M BMC Psychiatry; 2021 Jan; 21(1):64. PubMed ID: 33509135 [TBL] [Abstract][Full Text] [Related]
12. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408 [TBL] [Abstract][Full Text] [Related]
13. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease. Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K; Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117 [TBL] [Abstract][Full Text] [Related]
14. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease. Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366 [TBL] [Abstract][Full Text] [Related]
15. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318 [TBL] [Abstract][Full Text] [Related]
16. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study. Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651 [TBL] [Abstract][Full Text] [Related]
17. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR; JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304 [TBL] [Abstract][Full Text] [Related]